Futura Medical (LON:FUM) Shares Down 15.8% – Should You Sell?

Futura Medical plc (LON:FUM)’s stock price dropped 15.8% on Thursday . The stock traded as low as GBX 0.20 and last traded at GBX 0.28. 18,645,404 shares changed hands during trading, an increase of 102% from the average daily volume of 9,214,374 shares. The stock had previously closed at GBX 0.33.

Futura Medical Stock Performance

The firm has a fifty day moving average of GBX 0.41 and a 200-day moving average of GBX 0.77. The stock has a market capitalization of £1.62 million, a price-to-earnings ratio of -0.10 and a beta of 0.02.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. On average, analysts predict that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.